Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases.

Janegova A, Janega P, Rychly B, Kuracinova K, Babal P.

Endokrynol Pol. 2015;66(2):132-6. doi: 10.5603/EP.2015.0020.

2.

Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.

Xu WS, Chan AC, Lee JM, Liang RH, Ho FC, Srivastava G.

J Med Virol. 1998 Dec;56(4):342-50.

PMID:
9829640
3.

Hashimoto's thyroiditis following Graves' disease.

Umar H, Muallima N, Adam JM, Sanusi H.

Acta Med Indones. 2010 Jan;42(1):31-5.

4.

Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.

Mukasa K, Noh JY, Kunii Y, Matsumoto M, Sato S, Yasuda S, Suzuki M, Ito K, Ito K.

Thyroid. 2011 Jan;21(1):37-41. doi: 10.1089/thy.2010.0050. Epub 2010 Oct 9.

PMID:
20932180
5.

Possible association of CEA expression with oxyphilic change but not with C-cell hyperplasia in Hashimoto's thyroiditis.

Gakiopoulou H, Litsiou E, Valaris K, Balafoutas D, Patsouris E, Tseleni-Balafouta S.

Endocr J. 2010;57(8):693-9. Epub 2010 Jul 3.

6.

Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.

Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.

Ai Zheng. 2006 Feb;25(2):136-42.

PMID:
16480574
7.

Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis.

Ohye H, Nishihara E, Sasaki I, Kubota S, Fukata S, Amino N, Kuma K, Miyauchi A.

Intern Med. 2006;45(6):385-9. Epub 2006 Apr 17.

8.

Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients.

Wiebolt J, Achterbergh R, den Boer A, van der Leij S, Marsch E, Suelmann B, de Vries R, van Haeften TW.

Eur J Endocrinol. 2011 May;164(5):789-94. doi: 10.1530/EJE-10-1172. Epub 2011 Mar 4.

9.

Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas.

Renné C, Ramos Lopez E, Steimle-Grauer SA, Ziolkowski P, Pani MA, Luther C, Holzer K, Encke A, Wahl RA, Bechstein WO, Usadel KH, Hansmann ML, Badenhoop K.

J Clin Endocrinol Metab. 2004 Nov;89(11):5810-4.

PMID:
15531546
10.

Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.

Jeon YK, Lee BY, Kim JE, Lee SS, Kim CW.

Head Neck. 2004 Jul;26(7):573-83.

PMID:
15229899
11.

Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.

Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M, Chatterjee KV, Lazarus JH, Pearce SH, Vaidya B, Gough SC, Franklyn JA.

Am J Med. 2010 Feb;123(2):183.e1-9. doi: 10.1016/j.amjmed.2009.06.030.

PMID:
20103030
12.

Graves' disease associated with alopecia areata developing after Hashimoto's thyroiditis.

Aşık M, Binnetoğlu E, Şen H, Tekeli Z, Uysal F, Ukinç K.

J Nippon Med Sch. 2013;80(6):467-9.

13.

[Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases].

Bossowski A, Czarnocka B, Stasiak-Barmuta A, Bardadin K, Urban M, Dadan J.

Endokrynol Pol. 2007 Jul-Aug;58(4):303-13. Polish.

PMID:
18058722
14.
15.

High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma.

Ryan JL, Morgan DR, Dominguez RL, Thorne LB, Elmore SH, Mino-Kenudson M, Lauwers GY, Booker JK, Gulley ML.

Lab Invest. 2009 Jan;89(1):80-90. doi: 10.1038/labinvest.2008.103. Epub 2008 Nov 10.

16.

Fas ligand gene polymorphisms are not associated with Hashimoto's thyroiditis and Graves' disease.

Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K.

Hum Immunol. 2003 Feb;64(2):285-9.

PMID:
12559631
17.

Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.

Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF.

Hum Pathol. 2001 Sep;32(9):963-9.

PMID:
11567226
18.

Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.

Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsui S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM.

Am J Pathol. 1998 Jan;152(1):191-8.

19.

[Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].

He JH, Zong YS, Zhang M, Zhong BL, Liang YJ, Liang XM.

Zhonghua Bing Li Xue Za Zhi. 2003 Jun;32(3):234-7. Chinese.

PMID:
12882689
20.

Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease.

Wu Z, Podack ER, McKenzie JM, Olsen KJ, Zakarija M.

Clin Exp Immunol. 1994 Dec;98(3):470-7.

Supplemental Content

Support Center